What shareholders can do to beat the market with BioLife Solutions Inc. (BLFS) stock

In the latest session, BioLife Solutions Inc. (NASDAQ: BLFS) closed at $21.55 up 0.28% from its previous closing price of $21.49. In other words, the price has increased by $+0.06 from its previous closing price. On the day, 223944 shares were traded. BLFS stock price reached its highest trading level at $21.94 during the session, while it also had its lowest trading level at $20.90.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored

Ratios:

For a deeper understanding of BioLife Solutions Inc.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.80 and its Current Ratio is at 3.70. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.

Upgrades & Downgrades

On October 19, 2021, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $61.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 23 when DE GREEF RODERICK sold 4,500 shares for $21.71 per share. The transaction valued at 97,695 led to the insider holds 79,719 shares of the business.

Wichterman Troy sold 121 shares of BLFS for $2,444 on Nov 22. The Chief Financial Officer now owns 45,231 shares after completing the transaction at $20.20 per share. On Nov 21, another insider, DE GREEF RODERICK, who serves as the COO & President of the company, sold 9,500 shares for $21.63 each. As a result, the insider received 205,485 and left with 84,219 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 5.97 while its Price-to-Book (P/B) ratio in mrq is 2.25.

Stock Price History:

Over the past 52 weeks, BLFS has reached a high of $45.85, while it has fallen to a 52-week low of $10.40. The 50-Day Moving Average of the stock is 22.03, while the 200-Day Moving Average is calculated to be 19.76.

Shares Statistics:

For the past three months, BLFS has traded an average of 354.71K shares per day and 438.04k over the past ten days. A total of 42.65M shares are outstanding, with a floating share count of 39.75M. Insiders hold about 2.70% of the company’s shares, while institutions hold 93.70% stake in the company. Shares short for BLFS as of Oct 13, 2022 were 2.57M with a Short Ratio of 2.61M, compared to 2.41M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 6.02% and a Short% of Float of 7.53%.

Earnings Estimates

There are 7 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.17 for the current quarter, with a high estimate of -$0.08 and a low estimate of -$0.21, while EPS last year was $0. The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.05 and low estimates of -$0.21.

Analysts are recommending an EPS of between -$2.01 and -$2.3 for the fiscal current year, implying an average EPS of -$2.19. EPS for the following year is -$0.28, with 6 analysts recommending between $0.08 and -$0.63.

Revenue Estimates

A total of 9 analysts believe the company’s revenue will be $42.06M this quarter.It ranges from a high estimate of $43.5M to a low estimate of $40.1M. As of the current estimate, BioLife Solutions Inc.’s year-ago sales were $33.8M, an estimated increase of 24.40% from the year-ago figure. For the next quarter, 8 analysts are estimating revenue of $44.52M, an increase of 19.30% less than the figure of $24.40% in the same quarter last year. There is a high estimate of $46.5M for the next quarter, whereas the lowest estimate is $43.5M.

A total of 9 analysts have provided revenue estimates for BLFS’s current fiscal year. The highest revenue estimate was $166M, while the lowest revenue estimate was $160.7M, resulting in an average revenue estimate of $163.4M. In the same quarter a year ago, actual revenue was $119.16M, up 37.10% from the average estimate. Based on 8 analysts’ estimates, the company’s revenue will be $200.79M in the next fiscal year. The high estimate is $210M and the low estimate is $193M. The average revenue growth estimate for next year is up 22.90% from the average revenue estimate for this year.